Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.

Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, Wagner DA, West KA, Degar AJ, Brennan AM, Miller PF.

Sci Transl Med. 2019 Jan 16;11(475). pii: eaau7975. doi: 10.1126/scitranslmed.aau7975.

PMID:
30651324
2.

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria.

Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, Reeder PJ, Momin MM, Bergeron CG, Guilmain SE, Miller PF, Kurtz CB, Falb D.

Nat Biotechnol. 2018 Oct;36(9):857-864. doi: 10.1038/nbt.4222. Epub 2018 Aug 13.

PMID:
30102294
3.

Family presence and participation during medical visits of heart failure patients: An analysis of survey and audiotaped communication data.

Cené CW, Haymore B, Laux JP, Lin FC, Carthron D, Roter D, Cooper LA, Chang PP, Jensen BC, Miller PF, Corbie-Smith G.

Patient Educ Couns. 2017 Feb;100(2):250-258. doi: 10.1016/j.pec.2016.09.001. Epub 2016 Sep 3.

4.

In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase/topoisomerase inhibitor with potent activity against Gram-positive, fastidious Gram-Negative, and atypical bacteria.

Huband MD, Bradford PA, Otterson LG, Basarab GS, Kutschke AC, Giacobbe RA, Patey SA, Alm RA, Johnstone MR, Potter ME, Miller PF, Mueller JP.

Antimicrob Agents Chemother. 2015 Jan;59(1):467-74. doi: 10.1128/AAC.04124-14. Epub 2014 Nov 10.

5.

Functional capacity in men and women following cardiac rehabilitation.

Gee MA, Viera AJ, Miller PF, Tolleson-Rinehart S.

J Cardiopulm Rehabil Prev. 2014 Jul-Aug;34(4):255-62. doi: 10.1097/HCR.0000000000000066.

PMID:
24977463
6.

Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.

Wallis RS, Jakubiec W, Mitton-Fry M, Ladutko L, Campbell S, Paige D, Silvia A, Miller PF.

PLoS One. 2012;7(1):e30479. doi: 10.1371/journal.pone.0030479. Epub 2012 Jan 18.

7.

Linezolid, the first oxazolidinone antibacterial agent.

Leach KL, Brickner SJ, Noe MC, Miller PF.

Ann N Y Acad Sci. 2011 Mar;1222:49-54. doi: 10.1111/j.1749-6632.2011.05962.x. Review.

PMID:
21434942
8.

Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.

Wallis RS, Jakubiec W, Kumar V, Bedarida G, Silvia A, Paige D, Zhu T, Mitton-Fry M, Ladutko L, Campbell S, Miller PF.

Antimicrob Agents Chemother. 2011 Feb;55(2):567-74. doi: 10.1128/AAC.01179-10. Epub 2010 Nov 15.

9.

Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.

Wallis RS, Jakubiec WM, Kumar V, Silvia AM, Paige D, Dimitrova D, Li X, Ladutko L, Campbell S, Friedland G, Mitton-Fry M, Miller PF.

J Infect Dis. 2010 Sep 1;202(5):745-51. doi: 10.1086/655471.

PMID:
20629533
10.

Key pathogens and emerging therapies in infectious diseases.

Miller PF, Mueller JP.

Curr Opin Pharmacol. 2009 Oct;9(5):535-6. doi: 10.1016/j.coph.2009.09.001. Epub 2009 Sep 18. No abstract available.

PMID:
19766536
11.

Severe Clostridium difficile colitis and reactive arthritis in a ten-year-old child.

Durand CL, Miller PF.

Pediatr Infect Dis J. 2009 Aug;28(8):750-1. doi: 10.1097/INF.0b013e31819bdaa3.

PMID:
19633524
12.
13.

Multi-element survey of wild edible fungi and blackberries in the UK.

Weeks CA, Croasdale M, Osborne MA, Hewitt L, Miller PF, Robb P, Baxter MJ, Warriss PD, Knowles TG.

Food Addit Contam. 2006 Feb;23(2):140-7.

PMID:
16449056
14.

Comparison of lufenuron and nitenpyram versus imidacloprid for integrated flea control.

Miller PF, Peters BA, Hort CA.

Vet Ther. 2001 Fall;2(4):285-92.

PMID:
19746650
15.

Syntactic and semantic processing in Hebrew readers with prelingual deafness.

Miller PF.

Am Ann Deaf. 2000 Dec;145(5):436-51.

PMID:
11191823
16.

Functional and biochemical characterization of Escherichia coli sugar efflux transporters.

Liu JY, Miller PF, Willard J, Olson ER.

J Biol Chem. 1999 Aug 13;274(33):22977-84.

17.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
18.

The identification of a new family of sugar efflux pumps in Escherichia coli.

Liu JY, Miller PF, Gosink M, Olson ER.

Mol Microbiol. 1999 Mar;31(6):1845-51.

19.

Stepwise approaches for estimating the intakes of chemicals in food.

Parmar B, Miller PF, Burt R.

Regul Toxicol Pharmacol. 1997 Aug;26(1 Pt 1):44-51. Review.

PMID:
9339479
20.
21.

Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.

Miller PF, Sulavik MC.

Mol Microbiol. 1996 Aug;21(3):441-8. Review.

PMID:
8866468
22.
25.

Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli.

Miller PF, Gambino LF, Sulavik MC, Gracheck SJ.

Antimicrob Agents Chemother. 1994 Aug;38(8):1773-9.

27.

Beta-endorphin response to exercise and mental stress in patients with ischemic heart disease.

Miller PF, Light KC, Bragdon EE, Ballenger MN, Herbst MC, Maixner W, Hinderliter AL, Atkinson SS, Koch GG, Sheps DS.

J Psychosom Res. 1993 Jul;37(5):455-65.

PMID:
8350288
28.
29.

Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial.

Uden S, Schofield D, Miller PF, Day JP, Bottiglier T, Braganza JM.

Aliment Pharmacol Ther. 1992 Apr;6(2):229-40.

PMID:
1600043
30.

A quantitative model for translational control of the GCN4 gene of Saccharomyces cerevisiae.

Abastado JP, Miller PF, Hinnebusch AG.

New Biol. 1991 May;3(5):511-24.

PMID:
1883814
31.

Selenium status in relation to reduced glutathione peroxidase activity in aspirin-sensitive asthma.

Pearson DJ, Suarez-Mendez VJ, Day JP, Miller PF.

Clin Exp Allergy. 1991 Mar;21(2):203-8.

PMID:
2043988
32.

Remedies for Common Cold Symptoms: Making sense of myriad drugs.

Miller PF.

Can Fam Physician. 1991 Jan;37:139-47.

33.
34.

cis-acting sequences involved in the translational control of GCN4 expression.

Miller PF, Hinnebusch AG.

Biochim Biophys Acta. 1990 Aug 27;1050(1-3):151-4.

PMID:
2207139
35.

Aging and pain perception in ischemic heart disease.

Miller PF, Sheps DS, Bragdon EE, Herbst MC, Dalton JL, Hinderliter AL, Koch GG, Maixner W, Ekelund LG.

Am Heart J. 1990 Jul;120(1):22-30.

PMID:
2360510
36.

Human selenium status and glutathione peroxidase activity in north-west England.

Pearson DJ, Day JP, Suarez-Mendez VJ, Miller PF, Owen S, Woodcock A.

Eur J Clin Nutr. 1990 Apr;44(4):277-83.

PMID:
2364917
37.

Small-bowel obstruction from bran cereal.

Miller DL, Miller PF, Dekker JJ.

JAMA. 1990 Feb 9;263(6):813-4. No abstract available.

PMID:
2153258
38.

Pharmacokinetics of prednisolone in children with nephrosis.

Miller PF, Bowmer CJ, Wheeldon J, Brocklebank JT.

Arch Dis Child. 1990 Feb;65(2):196-200.

40.

Nutritional considerations in a patient with gastroparesis.

Gentry P, Miller PF.

Diabetes Educ. 1989 Jul-Aug;15(4):374-6. No abstract available.

PMID:
2791864
41.

What every diabetes educator needs to know about hypoglycemia.

Kulkarni K, Miller PF, Dew N.

Diabetes Educ. 1989 Jan-Feb;15(1):28-9. No abstract available.

PMID:
2642796
43.

Bacterial uptake of aminoglycoside antibiotics.

Taber HW, Mueller JP, Miller PF, Arrow AS.

Microbiol Rev. 1987 Dec;51(4):439-57. Review. No abstract available.

44.

Factors that predict improvement in left ventricular ejection fraction after coronary angioplasty for acute myocardial infarction.

Brodie BR, Weintraub RA, Hansen CJ, Miller PF, LeBauer EJ, Katz JD, Stuckey TD.

Cathet Cardiovasc Diagn. 1987 Nov-Dec;13(6):372-80.

PMID:
2961450
45.

The separation of unbound prednisolone in plasma by centrifugal ultrafiltration.

Miller PF, Wheeldon J, Brocklebank JT.

J Pharm Pharmacol. 1987 Nov;39(11):939-41.

PMID:
2892921
46.

Emergency coronary angioplasty for acute myocardial infarction. Results from a community hospital.

Miller PF, Brodie BR, Weintraub RA, LeBauer EJ, Katz JD, Stuckey TD, Hansen CJ.

Arch Intern Med. 1987 Sep;147(9):1565-70.

PMID:
2957970
47.

Immunoregulatory treatment for minimal change nephrotic syndrome.

Miller PF.

Arch Dis Child. 1986 Jul;61(7):718-9. No abstract available.

48.

The lethal multiple congenital anomaly syndrome of polydactyly, sex reversal, renal hypoplasia, and unilobular lungs.

Donnai D, Young ID, Owen WG, Clark SA, Miller PF, Knox WF.

J Med Genet. 1986 Feb;23(1):64-71.

49.

Long term prognosis of recurrent haematuria.

Miller PF, Speirs NI, Aparicio SR, Lendon M, Savage JM, Postlethwaite RJ, Brocklebank JT, Houston IB, Meadow SR.

Arch Dis Child. 1985 May;60(5):420-5.

50.

Blood testing compared with urine testing in the long term control of diabetes.

Miller PF, Stratton C, Tripp JH.

Arch Dis Child. 1983 Apr;58(4):294-7.

Supplemental Content

Loading ...
Support Center